Activating mutations of TSH receptor

P Rodien1, S-C Ho, V Vlaeminck

  • 1Endocrinologie, Centre hospitalier universitaire d'Angers, 4 rue Larrey, 49033 Angers cedex 01, France. PaRodien@chu-angers.fr

Insights

Mutations in the Thyrotropin receptor cause hyperthyroidism by leading to constitutive activation or sensitization to hormones. These findings illuminate glycoprotein hormone receptor activation mechanisms.

Area of Science:

  • Endocrinology
  • Molecular Biology
  • Genetics

Background:

  • G protein-coupled receptor activation involves structural changes.
  • Constitutive receptor activation can lead to disease.
  • Thyrotropin receptor mutations are implicated in thyroid disorders.

Purpose of the Study:

  • Investigate the role of Thyrotropin receptor mutations in thyroid toxic adenomas.
  • Identify the genetic basis of familial non-autoimmune hyperthyroidism and neonatal hyperthyroidism.
  • Understand the mechanisms of glycoprotein hormone receptor activation.

Main Methods:

  • Analysis of somatic and germline mutations in the Thyrotropin receptor.
  • Studying receptor activation mechanisms through mutational studies.
  • Developing models of receptor activation based on experimental data.

Main Results:

  • Spontaneous somatic mutations in the Thyrotropin receptor cause thyroid toxic adenomas.
  • Germline mutations in the Thyrotropin receptor cause familial non-autoimmune and neonatal hyperthyroidism.
  • A mutation causing Thyrotropin receptor sensitization to hCG identified in familial gestational hyperthyroidism.

Conclusions:

  • Thyrotropin receptor mutations are a key cause of various hyperthyroidism forms.
  • Receptor activation models are evolving, suggesting complex extracellular-transmembrane domain interactions.
  • Mutation studies provide critical insights into glycoprotein hormone receptor function.

Related Concept Videos

Graves Disease II: Pathophysiology01:24

Graves Disease II: Pathophysiology

Graves’ disease is an autoimmune disorder characterized by the production of thyroid-stimulating immunoglobulins (TSI) that activate TSH receptors, leading to excessive synthesis and release of thyroid hormones (T3 and T4) and resulting in hyperthyroidism.Among all causes of hyperthyroidism, Graves’ disease is the most common and can happen at any age, though it is more frequent in women. It produces a hypermetabolic state with features such as weight loss, tachycardia, tremor, and heat...
Cancer-Critical Genes I: Proto-oncogenes01:33

Cancer-Critical Genes I: Proto-oncogenes

Genes usually encode proteins necessary for the proper functioning of a healthy cell. Mutations can often cause changes to the gene expression pattern, thereby altering the phenotype.
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
Receptor Tyrosine Kinases01:26

Receptor Tyrosine Kinases

Receptor tyrosine kinases or RTKs are membrane-bound receptors that phosphorylate specific tyrosine on protein substrates. RTKs regulate cellular growth, differentiation, survival, and migration. They contain an extracellular ligand binding domain, a transmembrane domain, and a cytosolic tail with intrinsic kinase activity. Several extracellular signaling molecules activate RTKs in one or more ways and relay the signal downstream. Ligands such as platelet-derived growth factor (PDGF) or...
Loss of Tumor Suppressor Gene Functions01:12

Loss of Tumor Suppressor Gene Functions

Tumor suppressor genes are normal genes that can slow down cell division, repair DNA mistakes, or program the cells for apoptosis in case of irreparable damage. Hence, they play an essential role in preventing the proliferation of damaged cells.
When the tumor suppressor genes develop mutations or are lost, cells start growing out of control, leading to cancer. However, a single functional copy of the tumor suppressor gene is enough for the cells to maintain their normal functions and cell...
tRNA Activation02:26

tRNA Activation

Aminoacyl-tRNA synthetases are present in both eukaryotes and bacteria. Though eukaryotes have 20 different aminoacyl-tRNA synthetases to couple to 20 amino acids, many bacteria do not have genes for all of these aminoacyl-tRNA synthetases. Despite this, they still use all 20 amino acids to synthesize their proteins. For instance, some bacteria do not have the gene encoding the enzyme that couples glutamine with its partner tRNA. In these organisms, one enzyme adds glutamic acid to all of the...